General considerations in intermittent drug therapy of pulmonary tuberculosis
- PMID: 4110537
- PMCID: PMC2467339
- DOI: 10.1136/pgmj.47.553.729
General considerations in intermittent drug therapy of pulmonary tuberculosis
Abstract
The advantages of intermittent chemotherapy for pulmonary tuberculosis are discussed and the results of several controlled trials summarized. Once-weekly therapy now appears a definite prospect.
The most appropriate approach to therapy at both national and individual physician level now seems to be a combination of unsupervised daily and supervised intermittent regimens.
Similar articles
-
Tuberculosis treatment: dangerous regimens?Int J Tuberc Lung Dis. 2001 Jan;5(1):1-3. Int J Tuberc Lung Dis. 2001. PMID: 11263509 No abstract available.
-
What about short course and intermittent chemotherapy for tuberculosis in children?Pediatr Infect Dis. 1982 Sep-Oct;1(5):298-303. doi: 10.1097/00006454-198209000-00003. Pediatr Infect Dis. 1982. PMID: 6984178 No abstract available.
-
[Drug therapy of tuberculosis].Dtsch Med Wochenschr. 1974 Aug 9;99(32):1627-30. doi: 10.1055/s-0028-1107999. Dtsch Med Wochenschr. 1974. PMID: 4135677 German. No abstract available.
-
[Chemotherapeutic studies on advanced tuberculosis in mice].Bibl Tuberc. 1965;21:31-96. Bibl Tuberc. 1965. PMID: 4301034 Review. French. No abstract available.
-
New trends in the chemotherapy of tuberculosis--current aspects.Pneumonologie. 1974 Jun 14;150(1):1-12. doi: 10.1007/BF02097148. Pneumonologie. 1974. PMID: 4135222 Review. No abstract available.
Cited by
-
Comparative blood levels and metabolism of INH and an INH-matrix preparation in fast and slow inactivators.Can Med Assoc J. 1973 Sep 15;109(6):483-7. Can Med Assoc J. 1973. PMID: 4742916 Free PMC article.
-
Compliance of patients and physicians: experience and lessons from tuberculosis-II.Br Med J (Clin Res Ed). 1983 Jul 9;287(6385):101-5. doi: 10.1136/bmj.287.6385.101. Br Med J (Clin Res Ed). 1983. PMID: 6407697 Free PMC article. No abstract available.
-
Pharmacokinetic factors in the modern drug treatment of tuberculosis.Clin Pharmacokinet. 1999 Aug;37(2):127-46. doi: 10.2165/00003088-199937020-00003. Clin Pharmacokinet. 1999. PMID: 10496301 Review.